SABPA Newsletter, September 2018
In This Issue
Upcoming Events
14th Annual SABPA Pacific Forum and 7th SABPA Bio-Partnering
Connect With Us
Subscribe to our WeChat 

SABPA Events

14th Annual SABPA Pacific Forum and 7th SABPA Bio-Partnering
Date: Saturday, September 29, 2018

Location: Hilton San Diego Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CA
Registration: http://www.sabpa.org/2018/07/14th-annual-sabpa-pacific-forum-and-6th-sabpa-bio-partnering/

The annual SABPA Pacific Forum has become an important platform to showcase the latest developments in biotech/pharmaceutical industry across the Pacific. Come and meet industry leaders and hear about the increasing integration of drug research and development around the globe, rapid changes in government regulations, and opening-up of the Chinese pharmaceutical market. Register now to learn how to seize these new opportunities. Visit www.sabpa.org for details.
Scan the registration code to take advantage of the early bird rate!

7th SABPA Bio-Partnering

Paralleled with Pacific Forum, Hilton Del Mar, September, 29, 2018
Co-Organizers: SABPA, ChinaBio
SABPA Bio-Partnering is a great platform to explore opportunities in licensing, investment, fund raising and other collaboration deals.  It is designed for you to pre-arrange 1-on-1 face-to-face meetings with potential partners/investors/entrepreneurs by using the EBD online tool Partnering360*.  Participants can upload their profile to the platform, and send invitations to other participants.   Once the invitations are accepted, the 30 min private meetings will be arranged automatically.   Participants will have access to pre-scheduled 1-on-1 meetings in designated meeting areas during the conference, as well as access to Partnering360 database all year round.   Bio-Partnering will be hosted at the same time and venue with SABPA Pacific Forum (09/29/2018).  Please check the link below for more details.
Who shall attend?
  • Entrepreneurs and executives from local biotech and pharmaceutical companies
  • Chinese pharmaceutical companies who are looking for collaboration opportunities
  • Investors from local firms and across Pacific
  • Biotech or pharmaceutical service providers
How to Participate?
Register for SABPA Bio-Partnering event and SABPA Pacific Forum at the link below:
      ($100, online only, includes: SABPA Pacific Forum, dinner, parking)
Receive a private Partnering360 log-in link sent by Whova after your registration
Access Partnering360 to setup your profile and schedule meetings. Step-by-step instruction is available here:     https://www.sabpa.org/1on1instruction2017/
Please act early to allow time for meeting arrangement (> 2 weeks prior to the event date)
Need Help? Please email: bio1on1@sabpa.org
* Partnering360is a 3rd party (EBD Group) online software used to schedule meetings for SABPA Bio-Partnering.

7th SABPA/ACS Chemistry Symposium

DATE:    Thursday, September 6, 2018
TIME:     6:00 – 6:30 PM    Registration, Networking and Light dinner        
6:30 – 7:15 PM     Dr. Jinglan Zhou, “Discovery of Ivacaftor, a CFTR
                                            Potentiator for the Treatment of Cystic Fibrosis”
7:15 – 8:00 PM     Professor John L. Wood, “Recent Efforts in the Synthesis                                    of Complex Natural Products”
PLACE:  Lilly Biotechnology Center, 10290 Campus Point Dr., San Diego, CA 92121
No walk-in attendees. 
John L. Wood is the Robert A. Welch Distinguished Professor of Chemistry and Biochemistry at Baylor University. He is also a Cancer Prevention Research Institute of Texas (CPRIT) Scholar and an Associate Editor for Tetrahedron Letters.

Dr. Wood received a B.A. degree from the University of Colorado in 1985 and a Ph.D. from the University of Pennsylvania in 1991. He then moved to Harvard University as an American Cancer Society postdoctoral fellow and continued studying natural products synthesis in the laboratories of Stuart Schreiber. He joined the faculty at Yale University in 1993 as an assistant professor and was promoted to full professor in 1998. In 2006, he joined the faculty at Colorado State University as the Albert I. Meyers Professor of Chemistry.  In 2013, Wood moved from Colorado State to Baylor.  In the words of Dr. Elizabeth Davis, executive vice president and provost at Baylor University, “Dr. Wood is an outstanding scientist and educator. He has an impressive academic research career and a great reputation as a teacher and mentor.  Dr. Wood has a passion for chemistry, and his work promises to push forward the frontiers of cancer research.”

Jinglan Zhou, PhD, Research Fellow I, Vertex Pharmaceuticals Incorporated

Dr. Jinglan Zhou obtained a B.S. and M.S. in chemistry from Sichuan University, China. After earning a Ph.D. from Auburn University in 1997 under the direction of Prof. Philip Shevlin, Jinglan joined CombiChem in 1998 which was acquired by DuPont Pharmaceuticals, BMS and Deltagen, respectively. Jinglan then spent a year at Anadys Pharmaceuticals and moved to Vertex Pharmaceuticals in 2004 where she is currently a Research Fellow I. During her career at Vertex, Jinglan has contributed to the advancement of >10 clinical candidates in the areas of cystic fibrosis and pain. Jinglan was a key member of the chemistry team that discovered Ivacaftor (VX-770), Lumacaftor (VX-809) and Tezacaftor (VX-661), the three marketed drugs for the treatment of cystic fibrosis. Together with her teammates, Jinglan received the Heroes of Chemistry award from American Chemistry Society in 2013 owing to her contributions to Ivacaftor, the first medicine to treat the underlying cause of cystic fibrosis. Jinglan is an author/inventor on over 45 publications/patents.


Topic: Federal SBIR grant application – lessons learned by a novice
Dr. Rong Yang will tell us his experiences in applying federal SBIR grant at Cloudbreak Therapeutics. — In 2016, Dr. Yang joined Cloudbreak Therapeutics, a startup company with a focus on eye diseases.
When: September 15 (Sat), 2018
6:30 – 7:00 pm Networking
7:00 – 8:30 pm Seminar


Irvine Ranch Water District,
15500 Sand Canyon Ave.,
Irvine, CA 92618
Organizer: SABPA OC/LA

Free Registration:

Registration is free but required (max 70 registrants).
Parking is free. WebEx link will be provided after registration to allow remote participation in the meeting. Light dinner/snacks provided.

Speaker: Rong Yang, PhD, Head of Research, Cloudbreak Therapeutics

Dr. Yang received his BS degree in Biochemistry from Peking University, Beijing, China. He obtained his Ph.D. degree in Biochemistry and Molecular Biology from The University of Wisconsin-Madison, Wisconsin. After graduation, he did cancer research as a postdoctoral fellow at Cedars-Sinai/UCLA School of Medicine. Dr. Yang joined Allergan PLC in 1999 to work in the Biology Department where he conducted research in ophthalmology and dermatology fields. His research at Allergan mainly focused on early stage drug discovery but he also touched all aspects of drug development. During the 16 years at Allergan, Dr. Yang gained valuable expertise in ocular and dermatological drug development. He led multidisciplinary teams and collaborative projects responsible for drug target validation, drug candidate selection, non-clinical pharmacology support for clinical development and IND submission. Dr. Yang co-authored about 16 peer-reviewed publications and 9 patents.

SABPA Announcement

Outcome of the 2018 SABPA Board of Directors Election

The SABPA Board of Directors (BOD) is the governing body that oversees the activities of SABPA organization. There are twenty-one (21) board directors with a three-year term. In 2018, five seats were open for the candidates seeking re-election and new election. This year, seven (7) qualified candidates entered the election. Based on the votes and the board policy of minimal 4-seats for the OCLA chapter, the following candidates were elected as board directors (alphabetical order) in 2018: Guang Chen, Hua Gong, Yi Liu, Kevin Shao, Tao Wu.
We would like to thank all candidates for their participation, as well as their strong leadership and remarkable contributions for SABPA’s success. The committee are also very grateful to the SABPA members for their great support of this BOD election.
Congratulations to re-elected and newly elected directors!
2018 SABPA BOD Election Committee
Huaina Li
Stephanie Shi
Peter Huang (chair)

Community Events

The China Healthcare Summit 2018
The Bridge to Innovation

When:    November 13-14, 2018
Where:   Shanghai, China
Register now:

SABPA Members: Save an Additional 20% on Registration with Discount Code: SABPA2018

BioCentury and BayHelix Present: The 5th China Healthcare Summit in Shanghai November 13-14, 2018. The China Summit is a VIP-only event for busy biopharma and life sciences executives and investors to get a first-hand look at the innovation, business and policy transformations taking place in China. The conference is THE place to meet the right Chinese investors and partners in an intimate setting.

Seating is limited, so register today to reserve your seat and “Early-Bird” discount.

8 Reasons to Join Us in Shanghai

> Two days of strategic sessions and keynotes tailored to help busy executives understand emerging opportunities and challenges in China..

> The China Summit report created by Insights Partner, McKinsey & Company. This exclusive analysis documents market trends and identifies business imperatives for biopharma and life sciences companies doing business in China.

> New for 2018: For the 1st time, the China Summit will feature a presenting company track to showcase biotechs from China, Asia and the West, hand-picked by BioCentury and BayHelix.

> New for 2018: A 1×1 meeting system will allow attendees to arrange face-to-face discussions with investors and corporate delegates.

> Learn how biopharma CEOs, heads of research and leading investors are leveraging China’s innovation, policy initiatives and access to capital markets in HK and domestic exchanges to build a globally facing industry.

> Three VIP receptions to network with senior-level executives and investors.

> The annual BayHelix Awards ceremony and lunch to celebrate R&D and commercial achievements in China.

> Multiple networking breaks throughout the event to meet peers across the China innovation ecosystem.

The China Summit agenda has been developed by an Organizing Committee that includes China industry KOLs and BioCentury’s editorial team. Simultaneous translation is provided in all strategic sessions.

Our Platinum Corporate Sponsors

Our Gold Corporate Sponsors
Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA) is an 501(c)(3) nonprofit organization founded in early 2002 by professionals and scholars from the Chinese community in San Diego. In 2005, we expanded to Orange County and Los Angeles. We invite all scholars, professionals and entrepreneurs of any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry in Southern California to join us as a member of SABPA.
Our Mission
  • Provide a forum to facilitate professional contact and communication among local Chinese American professionals in academia, biotech and pharmaceutical industries;
  • Foster professional growth, career improvement and personal development of our members;
  • Provide opportunities to educate local communities about the values of biomedical research and the benefits of biotech and pharmaceutical innovations;
  • Stimulate and facilitate the development of relationships between the U.S. and China in biotech and pharmaceutical communities.
  • To fulfill our mission, we will sponsor professional seminars, meetings, and symposia; share employment opportunity information in local biotech and pharmaceutical industry; sponsor social events; and disseminate information about local biotech and pharmaceutical companies.